Merck’s newly FDA-approved COVID-19 antiviral drug, molnupiravir, may pose severe health consequences despite being purchased in bulk by the Biden administration prior to its approval.
According to the New York Times, the purported wonder drug may have “the potential to cause mutations in human DNA.”
Of particular concern are pregnant women, because researchers say that “the drug could affect a fetus’s dividing cells, theoretically causing birth defects.” One researcher said “there is no circumstance” in which he would advise a pregnant woman to take the drug, as a result.
Buried in the middle of the New York Times article, the author explains that researchers are concerned the drug could “cause errors” in a patient’s DNA, or the DNA of an unborn child.
According to a team of researchers in North Carolina, those “errors” could cause DNA mutations that may “contribute to the development of cancer, or cause birth defects either in a developing fetus or through incorporation into sperm precursor cells.”
Hellbound and Down 